Gut bacteria may hold key to why arthritis drugs stop working in kids
NCT ID NCT04540432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at how the gut bacteria (microbiome) change in children with juvenile spondyloarthritis as they receive different treatments. Researchers will collect stool and blood samples from 25 children over several months to see if certain bacteria affect how well the drugs work. The goal is to understand why some children stop responding to treatment, which could help doctors choose better therapies in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors understand why some children stop responding to arthritis treatments, potentially leading to better personalized care.
- What could go wrong
- This is a very small, early pilot study with only 25 participants. It is designed to observe and describe, not to test a new treatment, so it may not lead to any direct changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE SPONDYLARTHROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM, Hopital Nord
RECRUITINGMarseille, France
-
Hopital des enfants, CHU de Toulouse
NOT_YET_RECRUITINGToulouse, France
-
Montpellier University Hospital, Arnaud de Villeneuve Hospital
RECRUITINGMontpellier, Hérault, 34295, France
-
Nîmes University Hospital
RECRUITINGNîmes, Gard, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.